1, global regional competition pattern of vaccine technology
(1) Distribution of technology source countries: the United States accounts for the highest proportion.
Previously, the world's largest source of vaccine technology was the United States, and the number of vaccine patent applications in the United States accounted for 42.438+0% of the total number of vaccine patent applications in the world; Followed by China, China's vaccine patent applications accounted for 2 1.79% of the global vaccine patent applications. Although Europe and Britain rank third and fourth, there is a big gap between them and the number of patent applications in the United States ranked first.
Statistical description: ① Make statistics according to the rule that each application displays a public text, and select the latest text of the public date for calculation. (2) According to the statistics of patent priority country, if there is no priority, it shall be calculated according to the country of acceptance. If there are more than one priority country, it shall be calculated according to the earliest priority country.
(2) Patent application trend: China overtook the United States on 20 19, and the European Union and Britain "chased each other".
From the trend, the number of vaccine patent applications in the United States was far ahead from 20 10 to 20 18 years, but it was overtaken by China after 20 19 years. In 2020, the number of vaccine patent applications in China was 2,020, and that in the United States dropped to 1224.
The number of vaccine patent applications in Europe and Britain shows a trend of "you chase after me", and there is little difference in the number of patent applications between the two countries every year. In 2020, there were 237 vaccine patent applications in Europe and 18 1 vaccine patent applications in Britain.
Statistical description: ① Make statistics according to the rule that each application displays a public text, and select the latest text of the public date for calculation. (2) According to the statistics of the country with patent priority, if there is no priority, it shall be calculated according to the country where the patent is accepted. If there are more than one priority country, it shall be calculated according to the earliest priority country.
(3) Distribution of patent applications in China: The cumulative number of patents in Beijing surpassed that in Jiangsu, ranking first.
In China, Beijing is the province with the largest number of vaccine patent applications in China, with a total of 1264 vaccine patent applications. At present, the number of vaccine patent applications in Guangdong and Jiangsu both exceeds 1000. At present, the top ten provinces in China are Shandong, Henan, Shanghai, Hubei, Sichuan, Zhejiang and Heilongjiang.
Description of statistical caliber: According to the address submitted by the patent applicant.
From the trend, from 20 10 to 2020, Beijing, Jiangsu, Shandong and Guangdong will "go hand in hand". In 2020, Jiangsu Province has the largest number of patent applications, reaching 270; Beijing takes the lead in 202 1. By August of 20021year, the number of patent applications in Beijing reached 102. From 20 10 to 2020, there is little difference in the number of vaccine patent applications in other provinces.
Description of statistical caliber: According to the address submitted by the patent applicant.
2. The global competition pattern of vaccine technology applicants
(1) patent applicant concentration: the market concentration is not high, and CR 10 fluctuates.
From August, 20 10 to August, 200210, global vaccine patent applicants showed a downward trend, from 12.50% in 20 10 to/in June, 200210. On the whole, the global concentration of vaccine patent applicants is not high, and the concentration is on the decline.
Statistical caliber description: market concentration -Cr 10 is the proportion of the patent applications of the top 10 applicants in the total application volume to the total patent applications in this field (where the number of patents will not be recalculated when there is a joint application).
(2)TOP 10 patent applicant
-Aggregates and trends: Imatix is far ahead.
Patent applications in global vaccine industry TOP 10. The applicants are Amatix Biotechnology Co., Ltd., GlaxoSmithKline Biotechnology Co., Ltd., Interwitt International Co., Ltd., Lanzhou Veterinary Research Institute of China Academy of Agricultural Sciences, US Department of Health and Human Services, Pleco Bioengineering Co., Ltd., Boehringer Ingerham Animal Health USA Co., Ltd., University Council of Pennsylvania, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, and Jiangsu Academy of Agricultural Sciences.
Among them, Imatix Biotechnology Co., Ltd. has the largest number of vaccine patent applications, with 464. GlaxoSmithKline Biological Co., Ltd. ranked second, with 366 vaccine patent applications.
Note: The number of joint applications is not excluded.
From the trend point of view, from 20 10 to 20 15, there is little difference in the number of vaccine patents applied by the top ten vaccine patent applicants in the world. Until 20 15, imatex began to excel, and the number of patent applications for imatex biological vaccine reached 1 18 in 20 16.
However, after 20 16, the number of patent applications for imatex biological vaccine decreased rapidly, but the number of patent applications for vaccines of other companies was lower than that of imatex biological every year.
-Distribution of patented technology: H04L29 has many subdivided fields.
At present, the number of patent applications in the global vaccine industry is TOP 10. The applicant's technology is mainly distributed in A6 1K39 subdivision, among which Imatix Bio, which ranks first in the number of vaccine patent applications in the world, has 224 patent applications in this subdivision; The largest number of patent applications in this segment is GlaxoSmithKline Biological Co., Ltd., with 303 patents.
(3) TOP 10 patent applicant with the highest market value: Pfizer Ireland Pharmaceutical ranked first.
Among the TOP 10 patents with the highest value in the global vaccine market, Wyeth holds two seats, and Pfizer Ireland Pharmaceutical Company owns the patent with the highest value in the global vaccine market, which is11570,000 US dollars.
Note: The most valuable patent refers to the simple family with the highest patent value in this technical field. At present, the statistical caliber is to select any patent with patent value in the same family for display according to the rule of excluding the duplication of a patent representative in each simple family.
(4) New entrants to patent application: five new entrants.
There are five new entrants in the world, namely Qingdao Haite Biomedical Co., Ltd., PLA Academy of Military Medical Sciences, Tiankang Bio-Co., Ltd., Irish Zhan Sen Science Company and Suzhou Shinuo Biotechnology Co., Ltd., and these five new entrants are more active in applying for vaccine patents in 2020, among which Irish Zhan Sen Science Company applied for the largest number of vaccine patents, with 27.
Definition of new entrant: an applicant who has only submitted a patent application in the past five years.
-For more data, please refer to Prospective Industry Research Institute's Report on In-depth Investigation and Investment Strategic Planning of China Vaccine Industry.